Intellectual Property

Patents and other proprietary rights are integral to Solazyme’s business. Company policy is to file timely patent applications to protect intellectual property rights. Where appropriate, Solazyme also relies upon trade secrets, know-how, continuing technological innovations and licensing opportunities to develop and maintain its competitive position.

Solazyme’s growing portfolio comprises a number of patent applications in varying stages of prosecution. The applications are directed to novel genetic engineering methods, assays, and gene and protein sequences to evolve microbes to perform desired biochemical functions.

Our issued patents can be found here.

Our published applications can be found here.

Solazyme believes that its own intellectual property and in-licensed technology solidify its position as the industry leader in genetic engineering for the commercialization of optimized microbes.

Solazyme’s bioprospecting and acquisition activities have yielded a large and genetically diverse collection of microorganisms. Solazyme continues to augment its strain collection through the acquisition of additional species of microbes capable of performing a diverse array of biochemical reactions.